Civica
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

07/12/2016
London-listed Spire Healthcare has announced confirmed its new chief executive and appointed a new chief operating officer.
06/12/2016
The Northern Ireland General Practitioners Committee has asked GP practices to hand in their resignations from the NHS in January, according to Pulse.
06/12/2016
Legal & General has agreed to a partnership with Doctor Care Anywhere, a digital healthcare firm.
05/12/2016
Cygnet Health Care has agreed to acquire Cambian Group’s adult services division for £377 million.
02/12/2016
The Competition & Markets Authority has today launched a market study into care homes for the elderly.


Alix Partners


Aurora Group chief executive Stephen Bradshaw tells Hannah Thompson how to overcome the hurdles of running a turnaround business in the children's care and education space
Read more...


Capita Healthcare Decisions' Andy Lockwood tells Ploy Radford about the company's analytical ambitions
Read more...


Christie + Co

The CQC's annual State of Care report shows a sector under strain, but a change in tone shows the regulator at least recognises the assault on operators' margins is unsustainable. HealthInvestor takes a look at the devil in the details...
Read more...


A panel of leading health sector experts have put together their action plan for saving the NHS
Read more...



HealthInvestor blog
The Competition & Markets Authority needs to pick its battles more carefully, argues Ploy Radford

Click here to view the Editor's blog


Clare Connell and Henry Hunt of Connell Consulting examine the implications to the UK care sector of dismantling the Calais ‘Jungle’
Candesic’s Dr Joe Taylor and Dr Michelle Tempest report on the grass-roots polarisation apparent at the major party conferences
The CQC’s annual State of Care report shows a sector under strain, but a change in tone shows the regulator at least recognises the assault on operators’ margins is unsustainable. HealthInvestor takes a look at the devil in the details…
Aurora Group chief executive Stephen Bradshaw tells Hannah Thompson how to overcome the hurdles of running a turnaround business in the children’s care and education space
A panel of leading health sector experts have put together their action plan for saving the NHS

Click here to search all feature articles